Topics

US FDA Asks Sponsors Of Discontinued Naloxones To Consider Return To Market

14:01 EDT 9 Jul 2019 | SCRIP

In announcing expedited assessments for new naloxone ANDAs, the agency also offers guidance to sponsors of discontinued products considering a...

      

Related Stories

 

Original Article: US FDA Asks Sponsors Of Discontinued Naloxones To Consider Return To Market

NEXT ARTICLE

More From BioPortfolio on "US FDA Asks Sponsors Of Discontinued Naloxones To Consider Return To Market"

Quick Search